ID   MK09_HUMAN              Reviewed;         424 AA.
AC   P45984; A8K0S3; B5BU66; Q15708; Q15710; Q15711; Q8N5C5;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 2.
DT   05-OCT-2010, entry version 118.
DE   RecName: Full=Mitogen-activated protein kinase 9;
DE            Short=MAP kinase 9;
DE            Short=MAPK 9;
DE            EC=2.7.11.24;
DE   AltName: Full=JNK-55;
DE   AltName: Full=Stress-activated protein kinase JNK2;
DE   AltName: Full=c-Jun N-terminal kinase 2;
GN   Name=MAPK9; Synonyms=JNK2, PRKM9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=95059066; PubMed=7969172;
RA   Sluss H.K., Barrett T., Derijard B., Davis R.J.;
RT   "Signal transduction by tumor necrosis factor mediated by JNK protein
RT   kinases.";
RL   Mol. Cell. Biol. 14:8376-8384(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=95095084; PubMed=8001819;
RA   Kallunki T., Su B., Tsigelny I., Sluss H.K., Derijard B., Moore G.,
RA   Davis R., Karin M.;
RT   "JNK2 contains a specificity-determining region responsible for
RT   efficient c-Jun binding and phosphorylation.";
RL   Genes Dev. 8:2996-3007(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   MEDLINE=96256293; PubMed=8654373;
RA   Gupta S., Barrett T., Whitmarsh A.J., Cavanagh J., Sluss H.K.,
RA   Derijard B., Davis R.J.;
RT   "Selective interaction of JNK protein kinase isoforms with
RT   transcription factors.";
RL   EMBO J. 15:2760-2770(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM BETA-2).
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-268.
RG   NIEHS SNPs program;
RL   Submitted (MAY-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA-2).
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INTERACTION WITH ATF7, AND FUNCTION.
RX   PubMed=10376527; DOI=10.1038/sj.onc.1202723;
RA   De Graeve F., Bahr A., Sabapathy K.T., Hauss C., Wagner E.F.,
RA   Kedinger C., Chatton B.;
RT   "Role of the ATFa/JNK2 complex in Jun activation.";
RL   Oncogene 18:3491-3500(1999).
RN   [11]
RP   REGULATION BY MAP2K4 AND MAP2K7, AND COFACTOR.
RX   MEDLINE=20517265; PubMed=11062067; DOI=10.1042/0264-6021:3520145;
RA   Fleming Y., Armstrong C.G., Morrice N., Paterson A., Goedert M.,
RA   Cohen P.;
RT   "Synergistic activation of stress-activated protein kinase 1/c-Jun N-
RT   terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein
RT   kinase kinase 4 (MKK4) and MKK7.";
RL   Biochem. J. 352:145-154(2000).
RN   [12]
RP   INTERACTION WITH SPAG9.
RX   PubMed=15693750; DOI=10.1042/BJ20041577;
RA   Jagadish N., Rana R., Selvi R., Mishra D., Garg M., Yadav S.,
RA   Herr J.C., Okumura K., Hasegawa A., Koyama K., Suri A.;
RT   "Characterization of a novel human sperm-associated antigen 9 (SPAG9)
RT   having structural homology with c-Jun N-terminal kinase-interacting
RT   protein.";
RL   Biochem. J. 389:73-82(2005).
RN   [13]
RP   INTERACTION WITH NFATC4.
RX   PubMed=17875713; DOI=10.1158/0008-5472.CAN-06-4788;
RA   Yao K., Cho Y.-Y., Bergen H.R. III, Madden B.J., Choi B.Y., Ma W.-Y.,
RA   Bode A.M., Dong Z.;
RT   "Nuclear factor of activated T3 is a negative regulator of Ras-JNK1/2-
RT   AP-1 induced cell transformation.";
RL   Cancer Res. 67:8725-8735(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183 AND TYR-185, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-185, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-183; TYR-185 AND
RP   THR-404, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) OF 7-362.
RX   PubMed=18801372; DOI=10.1016/j.jmb.2008.08.086;
RA   Shaw D., Wang S.M., Villasenor A.G., Tsing S., Walter D.,
RA   Browner M.F., Barnett J., Kuglstatter A.;
RT   "The crystal structure of JNK2 reveals conformational flexibility in
RT   the MAP kinase insert and indicates its involvement in the regulation
RT   of catalytic activity.";
RL   J. Mol. Biol. 383:885-893(2008).
RN   [19]
RP   VARIANTS [LARGE SCALE ANALYSIS] MET-13; ASN-56; THR-246 AND ILE-366.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Responds to activation by environmental stress and pro-
CC       inflammatory cytokines by phosphorylating a number of
CC       transcription factors, primarily components of AP-1 such as c-Jun
CC       and ATF2 and thus regulates AP-1 transcriptional activity. In T-
CC       cells, JNK1 and JNK2 are required for polarized differentiation of
CC       T-helper cells into Th1 cells.
CC   -!- FUNCTION: JNK2 isoforms display different binding patterns: alpha-
CC       1 and alpha-2 preferentially bind to c-Jun, whereas beta-1 and
CC       beta-2 bind to ATF2. However, there is no correlation between
CC       binding and phosphorylation, which is achieved at about the same
CC       efficiency by all isoforms. JUNB is not a substrate for JNK2
CC       alpha-2, and JUND binds only weakly to it.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K4
CC       and MAP2K7. Inhibited by dual specificity phosphatases, such as
CC       DUSP1.
CC   -!- SUBUNIT: Interacts with MECOM (By similarity). Binds to at least
CC       four scaffolding proteins, MAPK8IP1/JIP-1, MAPK8IP2/JIP-2,
CC       MAPK8IP3/JIP-3/JSAP1 and SPAG9/MAPK8IP4/JIP-4. These proteins also
CC       bind other components of the JNK signaling pathway. Interacts with
CC       NFATC4. Interacts with ATF7; the interaction does not
CC       phosphorylate ATF7 but acts as a docking site for ATF7-associated
CC       partners such as JUN.
CC   -!- INTERACTION:
CC       P15336:ATF2; NbExp=1; IntAct=EBI-713568, EBI-1170906;
CC       Q02248:Ctnnb1 (xeno); NbExp=1; IntAct=EBI-713568, EBI-397872;
CC       P05412:JUN; NbExp=1; IntAct=EBI-713568, EBI-852823;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=Alpha-2;
CC         IsoId=P45984-1; Sequence=Displayed;
CC       Name=Alpha-1;
CC         IsoId=P45984-2; Sequence=VSP_004835;
CC       Name=Beta-1;
CC         IsoId=P45984-3; Sequence=VSP_004834, VSP_004835;
CC       Name=Beta-2;
CC         IsoId=P45984-4; Sequence=VSP_004834;
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185, which activates
CC       the enzyme. Autophosphorylated in vitro.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC
CC       Ser/Thr protein kinase family. MAP kinase subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JNK2ID426.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/mapk9/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L31951; AAA56831.1; -; mRNA.
DR   EMBL; U09759; AAA74740.1; -; mRNA.
DR   EMBL; U34821; AAC50606.1; -; mRNA.
DR   EMBL; U35002; AAC50608.1; -; mRNA.
DR   EMBL; U35003; AAC50609.1; -; mRNA.
DR   EMBL; CR536580; CAG38817.1; -; mRNA.
DR   EMBL; AK289638; BAF82327.1; -; mRNA.
DR   EMBL; DQ066599; AAY46156.1; -; Genomic_DNA.
DR   EMBL; AB451302; BAG70116.1; -; mRNA.
DR   EMBL; AB451355; BAG70169.1; -; mRNA.
DR   EMBL; CH471165; EAW53759.1; -; Genomic_DNA.
DR   EMBL; CH471165; EAW53757.1; -; Genomic_DNA.
DR   EMBL; BC032539; AAH32539.1; -; mRNA.
DR   IPI; IPI00024673; -.
DR   IPI; IPI00220382; -.
DR   IPI; IPI00220383; -.
DR   IPI; IPI00303550; -.
DR   PIR; A55480; A55480.
DR   PIR; S71102; S71102.
DR   RefSeq; NP_001128516.1; -.
DR   RefSeq; NP_002743.3; -.
DR   RefSeq; NP_620707.1; -.
DR   RefSeq; NP_620708.1; -.
DR   RefSeq; NP_620709.1; -.
DR   UniGene; Hs.484371; -.
DR   PDB; 3E7O; X-ray; 2.14 A; A/B=7-362.
DR   PDB; 3NPC; X-ray; 2.35 A; A/B=1-364.
DR   PDBsum; 3E7O; -.
DR   PDBsum; 3NPC; -.
DR   ProteinModelPortal; P45984; -.
DR   DIP; DIP-270N; -.
DR   DIP; DIP-281N; -.
DR   IntAct; P45984; 29.
DR   MINT; MINT-1400230; -.
DR   STRING; P45984; -.
DR   PhosphoSite; P45984; -.
DR   REPRODUCTION-2DPAGE; P45984; -.
DR   PRIDE; P45984; -.
DR   Ensembl; ENST00000347470; ENSP00000321410; ENSG00000050748.
DR   Ensembl; ENST00000452135; ENSP00000394560; ENSG00000050748.
DR   GeneID; 5601; -.
DR   KEGG; hsa:5601; -.
DR   UCSC; uc003mls.2; human.
DR   UCSC; uc003mlt.2; human.
DR   UCSC; uc003mlu.2; human.
DR   UCSC; uc003mlv.2; human.
DR   CTD; 5601; -.
DR   GeneCards; GC05M179595; -.
DR   H-InvDB; HIX0005495; -.
DR   HGNC; HGNC:6886; MAPK9.
DR   HPA; CAB008910; -.
DR   MIM; 602896; gene.
DR   PharmGKB; PA30630; -.
DR   eggNOG; maNOG09445; -.
DR   HOVERGEN; HBG014652; -.
DR   OMA; NGVVKDQ; -.
DR   PhylomeDB; P45984; -.
DR   BRENDA; 2.7.11.24; 247.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; foxopathway; FoxO family signaling.
DR   Pathway_Interaction_DB; glypican_3pathway; Glypican 3 network.
DR   Pathway_Interaction_DB; il12_stat4pathway; IL12 signaling mediated by STAT4.
DR   Pathway_Interaction_DB; il2_1pathway; IL2-mediated signaling events.
DR   Pathway_Interaction_DB; p75ntrpathway; p75(NTR)-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 21752; -.
DR   ArrayExpress; P45984; -.
DR   Bgee; P45984; -.
DR   CleanEx; HS_MAPK9; -.
DR   Genevestigator; P45984; -.
DR   GermOnline; ENSG00000050748; Homo sapiens.
DR   GO; GO:0005654; C:nucleoplasm; EXP:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004705; F:JUN kinase activity; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.
DR   GO; GO:0010744; P:positive regulation of macrophage derived f...; IMP:BHF-UCL.
DR   InterPro; IPR008351; JNK_MAPK.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; FALSE_NEG.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Kinase; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    424       Mitogen-activated protein kinase 9.
FT                                /FTId=PRO_0000186273.
FT   DOMAIN       26    321       Protein kinase.
FT   NP_BIND      32     40       ATP (By similarity).
FT   MOTIF       183    185       TXY.
FT   ACT_SITE    151    151       Proton acceptor (By similarity).
FT   BINDING      55     55       ATP (By similarity).
FT   MOD_RES     183    183       Phosphothreonine.
FT   MOD_RES     185    185       Phosphotyrosine.
FT   MOD_RES     404    404       Phosphothreonine.
FT   VAR_SEQ     216    230       GELVKGCVIFQGTDH -> AEMVLHKVLFPGRDY (in
FT                                isoform Beta-1 and isoform Beta-2).
FT                                /FTId=VSP_004834.
FT   VAR_SEQ     378    424       DAAVSSNATPSQSSSINDISSMSTEQTLASDTDSSLDASTG
FT                                PLEGCR -> AQMQQ (in isoform Alpha-1 and
FT                                isoform Beta-1).
FT                                /FTId=VSP_004835.
FT   VARIANT      13     13       V -> M (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042260.
FT   VARIANT      56     56       K -> N (in a head & Neck squamous cell
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_042261.
FT   VARIANT     246    246       A -> T (in dbSNP:rs35421153).
FT                                /FTId=VAR_042262.
FT   VARIANT     268    268       G -> A (in dbSNP:rs35693958).
FT                                /FTId=VAR_025175.
FT   VARIANT     366    366       R -> I (in dbSNP:rs55736180).
FT                                /FTId=VAR_042263.
FT   CONFLICT     51     51       N -> S (in Ref. 1; AAA56831 and 3;
FT                                AAC50606/AAC50608/AAC50609).
FT   CONFLICT    377    377       S -> P (in Ref. 2; AAA74740).
FT   STRAND       10     15
FT   TURN         16     18
FT   STRAND       19     23
FT   STRAND       26     31
FT   STRAND       40     46
FT   STRAND       51     56
FT   HELIX        64     79
FT   STRAND       88     92
FT   TURN         98    100
FT   STRAND      105    109
FT   STRAND      112    114
FT   HELIX       115    118
FT   HELIX       125    136
FT   HELIX       140    144
FT   HELIX       154    156
FT   STRAND      157    159
FT   STRAND      165    167
FT   HELIX       194    197
FT   HELIX       206    210
FT   HELIX       232    240
FT   HELIX       246    250
FT   HELIX       254    261
FT   HELIX       271    274
FT   HELIX       277    279
FT   HELIX       286    301
FT   HELIX       312    316
FT   HELIX       319    322
FT   HELIX       349    360
SQ   SEQUENCE   424 AA;  48139 MW;  9C15DA79981290AF CRC64;
     MSDSKCDSQF YSVQVADSTF TVLKRYQQLK PIGSGAQGIV CAAFDTVLGI NVAVKKLSRP
     FQNQTHAKRA YRELVLLKCV NHKNIISLLN VFTPQKTLEE FQDVYLVMEL MDANLCQVIH
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTACTNF
     MMTPYVVTRY YRAPEVILGM GYKENVDIWS VGCIMGELVK GCVIFQGTDH IDQWNKVIEQ
     LGTPSAEFMK KLQPTVRNYV ENRPKYPGIK FEELFPDWIF PSESERDKIK TSQARDLLSK
     MLVIDPDKRI SVDEALRHPY ITVWYDPAEA EAPPPQIYDA QLEEREHAIE EWKELIYKEV
     MDWEERSKNG VVKDQPSDAA VSSNATPSQS SSINDISSMS TEQTLASDTD SSLDASTGPL
     EGCR
//
